2,40EUR

0,00EUR

0,00%

21:57:01

STU

Tianjin Zhong Xin Pharmaceutical Group Corporation für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 907496 / ISIN: CNE100000924

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Tianjin Zhong Xin Pharmaceutical Group Corporation Times and Sales (STU)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Tianjin Zhong Xin Pharmaceutical Group Corporation Ltd (S)

Weitere Meldungen

19:24		‘Time will tell whether that was a good bet’: My adviser got me a full SpaceX IPO allocation. Was I lucky?
19:05		The Crowd Is Dumping Oklo. Here's Why I'd Be Buying It Down 44%.
18:50		Larry Ellison Personally Guaranteed $40.4 Billion of His Son's Warner Bros. Discovery Deal. Now 12 States Have Sued to Block It, and Oracle Stock Has Fallen 34% This Month.
18:48		Meta's Open-Source AI Strategy Could Be Its Biggest Advantage
18:37		Tesla Sank 15% on Its Q2 Miss. Wall Street's Average Price Target Now Implies 29% Upside.
18:30		For Energy Investors, Is a Traditional Energy ETF a Better Bet Than Clean Energy?
18:30		Where Is the Floor for SpaceX Stock Right Now?
18:15		Energy Transfer vs. Occidental Petroleum: The Better Energy Buy for the Second Half of 2026
18:00		BYD Already Surpassed Ford, and It's Only Now Revving Up Ambitions. Here's How It Can Win.
17:50		Anthropic: Neues Claude Opus 5 soll Sicherheitslücken auf Mythos-5-Niveau finden
17:45		Microsoft Stock Is Near a 1-Year Low. That Could Change on July 29.
17:32		Better AI Infrastructure Stock: IREN or Nebius?
17:30		JPMorgan CEO Jamie Dimon Reveals the Chilling Moment He Knew It 'Might Be Goodbye' During Emergency Heart Surgery— and He Had One Request for His Wife: 'Call The Company...'
17:30		This ETF Is Down 7% From Its High. History Says Now Is a Smart Time to Invest.
17:02		Nebius Could Be a Big Winner in the AI Infrastructure Boom
17:00		Elon Musk Built Tesla and SpaceX While Working Over 100-Hour Weeks. He Says 'Vacations Will Kill You' and the Reasons Behind It Are as Chaotic as You'd Expect.
17:00		I Want Exposure to the AI Boom Without Buying Nvidia. Here's Why Bloom Energy Is My Pick.
16:57		Saudi-Led Coalition Strikes Houthi Targets In Response to Militia Attacks; Energy Markets Brace for Volatility
16:57		Kuwait Signs $16 Billion Pipeline Deal With Blackstone, KKR, Brookfield Despite Rising Regional Tensions
16:55		Dozens dead after buses collide in eastern Syria
16:45		13% Below Its IPO Price, Is SpaceX Stock a Buy?
16:30		Should You Buy Intel Stock as It Rebuilds Its Chip Empire?
16:17		Two Wall Street Analysts Just Set Price Targets on Sandisk $1,430 Apart. One of Them Is Going to Be Very Wrong.
16:16		United Rentals CFO Sells Shares After Earnings Pop. Should Investors Follow?
16:00		Smart Lock Switchbot Lock Ultra Vision Pro im Test: Nuki sieht dagegen alt aus
16:00		Could Investing $50,000 Into S&P 500 Index Funds Be Enough to Get Your Portfolio to $1 Million by Retirement?
16:00		Navitas Semiconductor Is Targeting AI's Hidden Power Problem
15:57		Philadelphia Voters Approve City-Run Retirement Savings Program: How It Would Work
15:34		This ETF Has More Than Doubled the S&P 500's Returns This Year, but Be Aware of This One Issue It Could Face in the Second Half of the Year.
15:06		The Clock Is Ticking on Wall Street's $1.5 Trillion Powder Keg, and History Says Time Is Almost Up
14:48		1 Reason to Buy Amazon Stock Before July 30 That Has Nothing to Do With AWS
14:34		Alphabet vs. Apple: Which Warren Buffett Favorite Is the Better Buy Right Now?
14:30		Intel, Tesla, IBM And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week
14:27		What Does the Dropbox CTO's Sale of Nearly 13,000 Company Shares Mean for Investors?
14:26		SpaceX: Starship-Testflug gelingt im zweiten Startversuch
14:24		Should You Buy Wingstop Stock Before July 29?
14:12		Offener Brief: Microsoft, Nvidia & Co. fordern offenes KI-Ökosystem
14:00		Benzinga Bulls and Bears: IBM, Super Micro, Tesla
14:00		Sell the Company for $400 Million? He’s Giving It Away Instead.
14:00		Blockbuster I.P.O.s Are Creating New Millionaires. Philanthropies Want a Cut.
14:00		SpaceX isn’t the wireless threat that investors fear — unless someone breaks this unspoken agreement
14:00		How Is SpaceX (SPCX) Already the Largest of 3,372 Holdings in This $97.7 Billion Vanguard ETF?
13:56		Intel vs. IonQ: Comparing Revenue Trends Between Artificial Intelligence and Quantum Computing Chipmakers
13:55		Nuclear Company Oklo Receives Startup Authorization for Groves Reactor, A Key Step In Its Regulatory Journey
13:53		Littelfuse vs. Corning: Big Tech Partnerships Win the Revenue War
13:39		Should You Forget SpaceX Stock?
13:11		This Capricor Insider Sold 24,000 Shares Before the Drop. With a New Catalyst on the Way, Is It Time to Buy?
13:00		Summer holiday car hire: drive a great deal and avoid hidden fees
12:55		Prediction: This Unstoppable ETF Will Crush the S&P 500 in 2026 and Beyond
12:36		Social Security's 2027 COLA Is Set for a Double Dose of History

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Beijing Hualian Hypermarket IBERSOL SGPS IGI Laboratories Hup Soon Global Corporation Superior Multi-Packaging

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	25.07.2026 20:09
Kaufwert:	EUR
	Hinzufügen Speichern

Tianjin Zhong Xin Pharmaceutical Group Corporation Aktie

WKN: 907496 / ISIN: CNE100000924

Tianjin Zhong Xin Pharmaceutical Group Corporation Times and Sales (STU)

Times and Sales

Analysen zu Tianjin Zhong Xin Pharmaceutical Group Corporation Ltd (S)

Weitere Meldungen